Carter Bankshares (CARE) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
23 Apr, 2026Executive summary
Net income for Q1 2026 was $85.8 million ($3.88 diluted EPS), up from $8.5 million ($0.38 EPS) in Q4 2025 and $9.0 million ($0.39 EPS) in Q1 2025, driven by a significant one-time transaction gain.
The sale of nonperforming loans related to James C. Justice, II resulted in a $80.0 million net gain, boosting EPS by $3.50 and tangible book value per share by $3.49.
Financial highlights
Net interest income rose to $35.9 million, up 3.8% sequentially and 19.2% year-over-year.
Net interest margin increased to 3.07% from 2.92% in Q4 2025 and 2.68% in Q1 2025.
Noninterest income surged to $71.0 million, mainly due to the $65.0 million transaction gain.
Noninterest expense was $31.0 million, flat sequentially but up $3.0 million year-over-year, with increases in salaries, data processing, and occupancy.
Efficiency ratio improved to 29.01% from 77.84% in Q4 2025, with adjusted efficiency ratio at 72.66%.
Outlook and guidance
Management expects continued loan growth, supported by a healthy pipeline and funding from prior construction commitments over the next 12–18 months.
The balance sheet remains slightly liability sensitive, positioning for potential Fed rate cuts to further support margin expansion.
Latest events from Carter Bankshares
- Director elections, executive pay, auditor ratification, and ESG priorities headline the 2026 proxy.CARE
Proxy filing15 Apr 2026 - Votes will be cast on director elections, executive pay, and auditor ratification for 2026.CARE
Proxy filing15 Apr 2026 - Net income and assets grew in 2025, with strong capital, liquidity, and improved margins.CARE
Q4 20255 Feb 2026 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG efforts.CARE
Proxy Filing2 Dec 2025 - Loan and net interest income growth offset by asset quality pressures from a large nonaccrual loan.CARE
Q3 202521 Nov 2025 - Earnings rose on higher net interest income and loan growth, with strong capital and liquidity.CARE
Q2 20254 Aug 2025 - Q3 net income increased, margins improved, and major litigation was resolved.CARE
Q3 202413 Jun 2025 - Net income fell as a large NPL persisted, but capital and liquidity remain strong.CARE
Q2 202413 Jun 2025 - Q1 2025 net income surged 55% year-over-year, with strong capital and loan growth.CARE
Q1 20256 Jun 2025